January 18, 2021January 18, 2021
Sjögren’s Foundation Favors COVID-19 Vaccination for Patients
News
The Sjögren’s Foundation is recommending that people with Sjögren’s syndrome ages 16 and older be vaccinated against COVID-19 infection, ... Read more
January 4, 2021January 4, 2021
Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s
News
In-hospital mortality, the length of a hospital stay, and hospitalization charges for people with acute kidney injury and Sjögren’s ... Read more
December 22, 2020January 11, 2021
Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue
News
A technique that delivers low electric currents to stimulate specific parts of the brain can safely reduce fatigue in ... Read more
December 21, 2020December 21, 2020
Higher Risk of Blood Clots With COVID-19 Infection Seen in Study
News
People with Sjögren’s syndrome and other systemic autoimmune rheumatic diseases (SARDs) may be at a greater risk of severe ... Read more
December 14, 2020December 14, 2020
RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial
News
RSLV-132, an investigational treatment for autoimmune conditions, led to significant and clinically meaningful reductions in patient-reported fatigue in people ... Read more
December 7, 2020December 7, 2020
Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation
News
Primary Sjogren’s syndrome (pSS) patients have less diversity in their gut microbiome — with less abundant beneficial bacteria but ... Read more
November 30, 2020November 30, 2020
Sjogren’s Foundation Welcomes Applications for 2021 Research Grants
News
Applications for a next round of Sjögren’s Foundation research grants are being accepted from U.S. investigators working to better ... Read more
November 26, 2020November 25, 2020
New $100M Program Aims to Improve Diversity in Clinical Trials
News, syndicated
A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of ... Read more
November 23, 2020November 23, 2020
Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests
News
Primary Sjögren’s syndrome (pSS) syndrome can be classified based on the extent of organ involvement, fatigue, and pain, with ... Read more
November 16, 2020November 16, 2020
LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures
News
Wize Pharma‘s LO2A eye drops result in clinically meaningful improvements in dry eye signs and symptoms in people with Sjögren’s ... Read more
November 9, 2020November 9, 2020
Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests
News
Long-term use of hydroxychloroquine significantly lowers the risk of coronary artery disease, the most common form of heart disease, in ... Read more
November 2, 2020November 2, 2020
Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s
News
An immune regulatory molecule known as NEAT1 is produced at greater levels in the immune T-cells of people with ... Read more

November 9, 2020November 9, 2020

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

News

Long-term use of hydroxychloroquine significantly lowers the risk of coronary artery disease, the most common form of heart disease, in people with Sjögren’s syndrome, a data study in Taiwan suggested. ... Read more

November 2, 2020November 2, 2020

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s

News

An immune regulatory molecule known as NEAT1 is produced at greater levels in the immune T-cells of people with primary Sjogren’s syndrome, and these levels seem to correlate with ... Read more

October 26, 2020October 26, 2020

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

News

Using the PI3K-delta inhibitor seletalisib as an add-on to standard treatment showed a trend toward easing disease activity and dryness, and significantly lowered patient-reported fatigue in people with primary ... Read more

October 19, 2020October 19, 2020

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

News

The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a part of the National Institutes of Health, has awarded a $3.7 million grant to advance studies investigating which genes ... Read more

October 12, 2020October 12, 2020

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

News

The use of sialendoscopy, an endoscopic tool to examine and treat the salivary glands, can be used to irrigate the major salivary glands with saline to increase salivation and lessen ... Read more

September 30, 2020September 30, 2020

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

News

Interleukin-38, an immune signaling molecule known as IL-38, can reduce the inflammatory activity of a type of immune cells involved in primary Sjögren’s syndrome (pSS), and may be a ... Read more

September 21, 2020September 21, 2020

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

News

The arginase 1 protein appears to protect from dryness symptoms associated with Sjögren’s syndrome, potentially by lowering gland inflammation and increasing fluid secretion, a new study in mice indicates. The ... Read more

September 14, 2020September 14, 2020

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

News

Attention deficits may underlie the cognitive impairment that impacts a substantial portion of Sjögren’s syndrome patients with neurological symptoms, according to a new study. Such impairment is likely to ... Read more

September 9, 2020September 9, 2020

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

News

The tumor protein CA153 may be a valuable blood biomarker for the early diagnosis and treatment of interstitial lung disease (ILD) in people with primary Sjögren’s syndrome (pSS), a recent ... Read more

September 2, 2020September 2, 2020

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

News

High activity levels in immune-related genes are associated with the malfunction of immune cells isolated from people with primary Sjogren’s syndrome, a small study revealed. Such increased gene activity ... Read more

Sjögren’s Foundation Favors COVID-19 Vaccination for Patients

Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

New $100M Program Aims to Improve Diversity in Clinical Trials

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s